New safety plan for agents used to treat chemotherapy related anemia
FDA Announces New Safety Plan for Agents Used to Treat Chemotherapy-Related Anemia – The U.S. Food and Drug Administration today approved a risk management program to inform healthcare providers and their patients about the risks of a class of drugs called Erythropoiesis-Stimulating Agents (ESAs).